FONTI, ROSA
FONTI, ROSA
Dipartimento di Scienze biomediche avanzate
99mTc-monoclonal antibody radiolabeled via hydrazino nicotinamide derivative for imaging disialoganglioside G(D2)-positive tumors
1999 Fonti, R.; Cheung, N. -K. V.; Bridger, G. J.; Guo, H. -F.; Abrams, M. J.; Larson, S. M.
Measurement of P-glycoprotein expression in multidrug-resistant human neuroblastoma cell lines using self-competitive binding assay
1996 Levchenko, A.; Mehta, B. M.; Spengler, B. A.; Narkar, A. A.; Fonti, R.; Biedler, J. L.; Tsuruo, T.; Larson, S. M.
Ig antibody levels to Helicobacter pylori and histology of antral gastritis and duodenal ulcer: What is the correlation?
1992 Perrella, O.; Liguori, G.; Cattaneo, D.; Morelli, L.; Precchia, E.; Morisco, E.; Fonti, R.; Marinelli, P.
Measurement of P-glycoprotein expression in human neuroblastoma xenografts using in vitro quantitative autoradiography
1999 Fonti, R.; Levchenko, A.; Mehta, B. M.; Zhang, J.; Tsuruo, T.; Larson, S. M.
Heterogeneity of SSTR2 expression assessed by 68Ga-DOTATOC PET/CT using coefficient of variation in patients with neuroendocrine tumors
2022 Fonti, Rosa; Panico, Mariarosaria; Pellegrino, Sara; Pulcrano, Alessandro; Vastarella, LUISA ALESSIA; HAKKAK MOGHADAM TORBATI, Armin; Giuliano, Mario; Palmieri, Giovannella; DE PLACIDO, Sabino; DEL VECCHIO, Silvana
Liposomal doxorubicin supercharge-containing front-line treatment in patients with advanced-stage diffuse large B-cell lymphoma or classical Hodgkin lymphoma: Preliminary results of a single-centre phase II study
2022 Picardi, Marco; Giordano, Claudia; Pugliese, Novella; Esposito, Maria; Fatigati, Melania; Muriano, Francesco; Rascato, Maria G; Pepa, Roberta Della; D'Ambrosio, Alessandro; Vigliar, Elena; Troncone, Giancarlo; Russo, Daniela; Mascolo, Massimo; Esposito, Giovanni; Prastaro, Mariella; Esposito, Roberta; Tocchetti, Carlo G; Fonti, Rosa; Mainolfi, Ciro; Del Vecchio, Silvana; Pane, Fabrizio
PET-based volumetric biomarkers for risk stratification of non-small cell lung cancer patients
2021 Pellegrino, S; Fonti, R; Pulcrano, A; Del Vecchio, S
A reversible shift of driver dependence from EGFR to Notch1 in non-small cell lung cancer as a cause of resistance to tyrosine kinase inhibitors.
2021 Iommelli, F; De Rosa, V; Terlizzi, C; Fonti, R; Camerlingo, R; Stoppelli, Mp; Stewart, Ca; Byers, La; Piwnica-Worms, D; Del Vecchio, S.
Non-canonical role of PDK1 as a negative regulator of apoptosis through macromolecular complexes assembly at the ER-mitochondria interface in oncogene-driven NSCLC
2021 De Rosa, V; Iommelli, F; Terlizzi, C; Leggiero, E; Camerlingo, R; Altobelli, Gg; Fonti, R; Pastore, L; Del Vecchio, S
Prognostic role of FDG PET/CT in patients with differentiated thyroid cancer treated with 131-iodine empiric therapy
2017 Salvatore, Barbara; Klain, Michele; Nicolai, Emanuele; D'Amico, Domenico; De Matteis, Gianluca; Raddi, Marco; Fonti, Rosa; Pellegrino, Teresa; Storto, Giovanni; Cuocolo, Alberto; Pace, Leonardo
2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography/computed tomography in primary extranodal lymphomas: treatment response evaluation and prognosis
2020 Salvatore, Barbara; Fonti, Rosa; De Renzo, Amalia; Pellegrino, Sara; Ferrara, Ida L; Mainolfi, Ciro G; Marano, Luana; Selleri, Carmine; Pane, Fabrizio; Del Vecchio, Silvana; Pace, Leonardo
Preclinical imaging for targeting cancer immune evasion
2020 Terlizzi, C; De Rosa, V; Iommelli, F; Altobelli, Gg; Fonti, R; Del Vecchio, S
2-deoxy-2[F-18] fluoro-D-GLUCOSE POSITRON EMISSION TOMOGRAPHY Deauville scale and core-needle biopsy to determine successful management after six doxorubicin, bleomycin, vinblastine and dacarbazine cycles in advanced-stage Hodgkin lymphoma
2020 Picardi, M.; Fonti, R.; Della Pepa, R.; Giordano, C.; Pugliese, N.; Nicolai, E.; Salvatore, M.; Mainolfi, C.; Venetucci, P.; Rascato, M. G.; Cappuccio, I.; Mascolo, M.; Vigliar, E.; Troncone, G.; Del Vecchio, S.; Pane, F.
Brain metastases unresponsive to immunotherapy detected by 18F-FDG-PET/CT in a patient with melanoma
2020 Fonti, R; Pellegrino, S; Mainolfi, Cg; Matano, E; Del Vecchio, S
Monitoring reversal of MET-mediated resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer using 3'-deoxy-3'-[18F]-fluorothymidine positron emission tomography
2014 Iommelli, F; De Rosa, V; Gargiulo, Sara; Panico, M; Monti, M; Greco, Adelaide; Gramanzini, M; Ortosecco, G; Fonti, R; Brunetti, Arturo; DEL VECCHIO, Silvana
18F-FDG-PET/CT, 99mTc-MIBI and MRI in the prediction of outcome of patients with multiple myeloma: a comparative study
2015 Fonti, R; Pace, L; Cerchione, C; Catalano, L; Salvatore, B; DE LUCA, Serena; Pane, Fabrizio; Salvatore, Marco; DEL VECCHIO, Silvana
Reversal of Warburg effect and reactivation of oxidative phosphorylation by differential inhibition of EGFR signaling pathways in non-small cell lung cancer.
2015 De Rosa, V; Iommelli, F; Monti, M; Fonti, R; Votta, G; Stoppelli, Mp; DEL VECCHIO, Silvana
Detection of leptomeningeal involvement by 18F-FDG-PET/CT in a patient with non-Hodgkin lymphoma
2016 Fonti, Rosa; Salvatore, Barbara; DE RENZO, Amalia; Nicolai, E; DEL VECCHIO, Silvana
Multimodal imaging with 18F-FDG-PET/CT and 111In-Octreotide SPECT in patients with metastatic medullary thyroid carcinoma
2016 DE LUCA, Serena; Fonti, Rosa; Camera, Luigi; Salvatore, Barbara; Faggiano, Antongiulio; Ciarmiello, Andrea; Segreto, Sabrina; Colao, Annamaria; Salvatore, Marco; DEL VECCHIO, Silvana
Evaluation of metabolic response with 18F-FDG PET-CT in patients with advanced or recurrent thymic epithelial tumors.
2017 Segreto, Sabrina; Fonti, R; Ottaviano, Margaret; Pellegrino, Sara; Pace, L; Damiano, Vincenzo; Palmieri, Giovannella; DEL VECCHIO, Silvana
| Titolo | Tipologia | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|---|
| 99mTc-monoclonal antibody radiolabeled via hydrazino nicotinamide derivative for imaging disialoganglioside G(D2)-positive tumors | 1.1 Articolo in rivista | 1999 | Fonti, R.; Cheung, N. -K. V.; Bridger, G. J.; Guo, H. -F.; Abrams, M. J.; Larson, S. M. | |
| Measurement of P-glycoprotein expression in multidrug-resistant human neuroblastoma cell lines using self-competitive binding assay | 1.1 Articolo in rivista | 1996 | Levchenko, A.; Mehta, B. M.; Spengler, B. A.; Narkar, A. A.; Fonti, R.; Biedler, J. L.; Tsuruo, T.; Larson, S. M. | |
| Ig antibody levels to Helicobacter pylori and histology of antral gastritis and duodenal ulcer: What is the correlation? | 1.1 Articolo in rivista | 1992 | Perrella, O.; Liguori, G.; Cattaneo, D.; Morelli, L.; Precchia, E.; Morisco, E.; Fonti, R.; Marinelli, P. | |
| Measurement of P-glycoprotein expression in human neuroblastoma xenografts using in vitro quantitative autoradiography | 1.1 Articolo in rivista | 1999 | Fonti, R.; Levchenko, A.; Mehta, B. M.; Zhang, J.; Tsuruo, T.; Larson, S. M. | |
| Heterogeneity of SSTR2 expression assessed by 68Ga-DOTATOC PET/CT using coefficient of variation in patients with neuroendocrine tumors | 1.1 Articolo in rivista | 2022 | Fonti, Rosa; Panico, Mariarosaria; Pellegrino, Sara; Pulcrano, Alessandro; Vastarella, LUISA ALESSIA; HAKKAK MOGHADAM TORBATI, Armin; Giuliano, Mario; Palmieri, Giovannella; DE PLACIDO, Sabino; DEL VECCHIO, Silvana | |
| Liposomal doxorubicin supercharge-containing front-line treatment in patients with advanced-stage diffuse large B-cell lymphoma or classical Hodgkin lymphoma: Preliminary results of a single-centre phase II study | 1.1 Articolo in rivista | 2022 | Picardi, Marco; Giordano, Claudia; Pugliese, Novella; Esposito, Maria; Fatigati, Melania; Muriano, Francesco; Rascato, Maria G; Pepa, Roberta Della; D'Ambrosio, Alessandro; Vigliar, Elena; Troncone, Giancarlo; Russo, Daniela; Mascolo, Massimo; Esposito, Giovanni; Prastaro, Mariella; Esposito, Roberta; Tocchetti, Carlo G; Fonti, Rosa; Mainolfi, Ciro; Del Vecchio, Silvana; Pane, Fabrizio | |
| PET-based volumetric biomarkers for risk stratification of non-small cell lung cancer patients | 1.1 Articolo in rivista | 2021 | Pellegrino, S; Fonti, R; Pulcrano, A; Del Vecchio, S | |
| A reversible shift of driver dependence from EGFR to Notch1 in non-small cell lung cancer as a cause of resistance to tyrosine kinase inhibitors. | 1.1 Articolo in rivista | 2021 | Iommelli, F; De Rosa, V; Terlizzi, C; Fonti, R; Camerlingo, R; Stoppelli, Mp; Stewart, Ca; Byers, La; Piwnica-Worms, D; Del Vecchio, S. | |
| Non-canonical role of PDK1 as a negative regulator of apoptosis through macromolecular complexes assembly at the ER-mitochondria interface in oncogene-driven NSCLC | 1.1 Articolo in rivista | 2021 | De Rosa, V; Iommelli, F; Terlizzi, C; Leggiero, E; Camerlingo, R; Altobelli, Gg; Fonti, R; Pastore, L; Del Vecchio, S | |
| Prognostic role of FDG PET/CT in patients with differentiated thyroid cancer treated with 131-iodine empiric therapy | 1.1 Articolo in rivista | 2017 | Salvatore, Barbara; Klain, Michele; Nicolai, Emanuele; D'Amico, Domenico; De Matteis, Gianluca; Raddi, Marco; Fonti, Rosa; Pellegrino, Teresa; Storto, Giovanni; Cuocolo, Alberto; Pace, Leonardo | |
| 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography/computed tomography in primary extranodal lymphomas: treatment response evaluation and prognosis | 1.1 Articolo in rivista | 2020 | Salvatore, Barbara; Fonti, Rosa; De Renzo, Amalia; Pellegrino, Sara; Ferrara, Ida L; Mainolfi, Ciro G; Marano, Luana; Selleri, Carmine; Pane, Fabrizio; Del Vecchio, Silvana; Pace, Leonardo | |
| Preclinical imaging for targeting cancer immune evasion | 1.1 Articolo in rivista | 2020 | Terlizzi, C; De Rosa, V; Iommelli, F; Altobelli, Gg; Fonti, R; Del Vecchio, S | |
| 2-deoxy-2[F-18] fluoro-D-GLUCOSE POSITRON EMISSION TOMOGRAPHY Deauville scale and core-needle biopsy to determine successful management after six doxorubicin, bleomycin, vinblastine and dacarbazine cycles in advanced-stage Hodgkin lymphoma | 1.1 Articolo in rivista | 2020 | Picardi, M.; Fonti, R.; Della Pepa, R.; Giordano, C.; Pugliese, N.; Nicolai, E.; Salvatore, M.; Mainolfi, C.; Venetucci, P.; Rascato, M. G.; Cappuccio, I.; Mascolo, M.; Vigliar, E.; Troncone, G.; Del Vecchio, S.; Pane, F. | |
| Brain metastases unresponsive to immunotherapy detected by 18F-FDG-PET/CT in a patient with melanoma | 1.1 Articolo in rivista | 2020 | Fonti, R; Pellegrino, S; Mainolfi, Cg; Matano, E; Del Vecchio, S | |
| Monitoring reversal of MET-mediated resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer using 3'-deoxy-3'-[18F]-fluorothymidine positron emission tomography | 1.1 Articolo in rivista | 2014 | Iommelli, F; De Rosa, V; Gargiulo, Sara; Panico, M; Monti, M; Greco, Adelaide; Gramanzini, M; Ortosecco, G; Fonti, R; Brunetti, Arturo; DEL VECCHIO, Silvana | |
| 18F-FDG-PET/CT, 99mTc-MIBI and MRI in the prediction of outcome of patients with multiple myeloma: a comparative study | 1.1 Articolo in rivista | 2015 | Fonti, R; Pace, L; Cerchione, C; Catalano, L; Salvatore, B; DE LUCA, Serena; Pane, Fabrizio; Salvatore, Marco; DEL VECCHIO, Silvana | |
| Reversal of Warburg effect and reactivation of oxidative phosphorylation by differential inhibition of EGFR signaling pathways in non-small cell lung cancer. | 1.1 Articolo in rivista | 2015 | De Rosa, V; Iommelli, F; Monti, M; Fonti, R; Votta, G; Stoppelli, Mp; DEL VECCHIO, Silvana | |
| Detection of leptomeningeal involvement by 18F-FDG-PET/CT in a patient with non-Hodgkin lymphoma | 1.1 Articolo in rivista | 2016 | Fonti, Rosa; Salvatore, Barbara; DE RENZO, Amalia; Nicolai, E; DEL VECCHIO, Silvana | |
| Multimodal imaging with 18F-FDG-PET/CT and 111In-Octreotide SPECT in patients with metastatic medullary thyroid carcinoma | 1.1 Articolo in rivista | 2016 | DE LUCA, Serena; Fonti, Rosa; Camera, Luigi; Salvatore, Barbara; Faggiano, Antongiulio; Ciarmiello, Andrea; Segreto, Sabrina; Colao, Annamaria; Salvatore, Marco; DEL VECCHIO, Silvana | |
| Evaluation of metabolic response with 18F-FDG PET-CT in patients with advanced or recurrent thymic epithelial tumors. | 1.1 Articolo in rivista | 2017 | Segreto, Sabrina; Fonti, R; Ottaviano, Margaret; Pellegrino, Sara; Pace, L; Damiano, Vincenzo; Palmieri, Giovannella; DEL VECCHIO, Silvana |